APOLIERCONSULT
Timeline
29 events since 2011Board
Capital
Filings
Financial
End
Address
20122014201620182020202220242026
2025
Merger: absorbed by MULTIPHARMADissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares3 points ▸
- MULTIPHARMA holds all the shares
- The operation takes effect in the accounts on 01-01-2025
- Power of attorney granted to
- The deed holds 10 more points.
Annual accounts 2024 filed PDFfull format · 38 days before the deadline
- Merger by absorption
- Board meeting of 03-04-2025
- The operation takes effect in the accounts on 01-01-2025
- The deed holds 6 more points.
Powers of attorney granted to , and 5 othersBoard meeting of 04-02-20259 points ▸
- Board meeting of 04-02-2025
- Power of attorney granted to
- Power of attorney granted to (director)
- Power of attorney granted to (director)
- Power of attorney granted to (director)
- Power of attorney granted to (director)
- Power of attorney granted to (director)
- Power of attorney granted to (director)
- Power of attorney granted to (director)
2024
Back to profit net €12,180 The net result is €12,180, after one loss-making year.
Annual accounts 2023 filed PDFfull format · 7 days before the deadline
Power of attorney granted to Board meeting of 20-02-20242 points ▸
- Board meeting of 20-02-2024
- Power of attorney granted to
Registered office moved from Lier to AnderlechtThe registered office moved from Lisperstraat 9, 2500 Lier to Marie Curiesquare 30, 1070 Anderlecht · General meeting of 22-01-20242 points ▸
- General meeting of 22-01-2024
- The registered office moved to Marie Curiesquare 30, 1070 Anderlecht
2023
Weakest financial year net -€27,426 The net result drops to -€27,426, the lowest from 2012 to 2024.
1 director appointed, 1 statutory auditor appointed, 2 resignations and resign · and (statutory auditor) appointed · acts as permanent representative · General meeting of 11-12-202314 points ▸
- General meeting of 11-12-2023
- resigns as director
- resigns as director
- appointed as director
- appointed as statutory auditor
- acts as permanent representative
- Board meeting of 11-12-2023
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
2 directors resigning, 2 reappointments and resign · and reappointed · Legal-form conversion: from private limited company (pre-2019) to private limited company6 points ▸
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Name in the articles, ApoLierConsult
- resigns as director
- resigns as director
- reappointed as director
- reappointed as director
- The deed holds 4 more points.
Annual accounts 2022 filed PDFmicro format · 30 days late
2022
Back to profit net €5,901 The net result is €5,901, after one loss-making year.
Annual accounts 2021 filed PDFmicro format · 61 days late
2021
Annual accounts 2020 filed PDFmicro format · 90 days late
2020
Annual accounts 2019 filed PDFmicro format · 123 days late
2019
Annual accounts 2018 filed PDFmicro format · 30 days late
2018
Annual accounts 2017 filed PDFmicro format · 92 days late
2017
Annual accounts 2016 filed PDFmicro format · 31 days late
2016
Highest result from 2012 to 2024 net €70,257 ▲43.2% The operating result of €102,283 and the net result of €70,257 are both a record.
Annual accounts 2015 filed PDFabbreviated format · 92 days late
2015
Liquidity more than doubled current ratio 2.23 The current ratio rises from 0.96 to 2.23. Short-term debt falls from €297,121 to €160,286.
Equity above €200,000 equity €211,649 ▲30.2% With a profit in every financial year since 2012, equity grows to €211,649.
Annual accounts 2014 filed PDFabbreviated format · 61 days late
2014
Equity above €150,000 equity €162,584 ▲48.6% With a profit in every financial year since 2012, equity grows to €162,584.
Annual accounts 2013 filed PDFabbreviated format · on the deadline day
2013
Equity above €100,000 equity €109,387 ▲148% With a profit in every financial year since 2012, equity grows to €109,387.
Annual accounts 2012 filed PDFabbreviated format · 61 days late
2011
IncorporationFounding capital of €18,550, €6,200 paid up · Founded by (partner and founder); (partner and founder) · (manager) and (manager) appointed5 points ▸
- Founded by (partner and founder)
- Founded by (partner and founder)
- The founding capital is €18,550
- appointed as manager
- appointed as manager
- The deed holds 3 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 17 October 2011 the Belgian Official Gazette published the deed of incorporation of APOLIERCONSULT.1 In 2024 the registered office moved to Anderlecht.2 has served as director since 2023.3 In 2025 the company was absorbed by merger into MULTIPHARMA.4